1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
| Autor: | Besse, B., Drilon, A.E., Cho, B.C., Camidge, D.R., Neal, J., Lin, C-C., Liu, S.V., Nagasaka, M., Kao, S.C-H., Felip, E., Van Der Wekken, A.J., Lin, C.C., Bauman, J.R., Gadgeel, S., Samant, M., Shen, J., Sun, Y., Zhu, V.W., Upadhyay, V.A., Lin, J.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S804-S805 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|